SCHEDULE: Dodge & Cox Discloses 6.9% Stake in GE Healthcare
Schedule 13G Filing
Dodge & Cox has reported a beneficial ownership of 31,312,064 shares, representing 6.9% of the outstanding common stock of GE Healthcare Technologies Inc., as of March 31, 2026.
Summary
- Dodge & Cox, an investment management firm, has filed a Schedule 13G indicating their beneficial ownership of GE Healthcare Technologies Inc. common stock.
- As of March 31, 2026, Dodge & Cox holds 31,312,064 shares, which constitutes 6.9% of the class of securities.
- The firm has sole voting power over 29,686,614 shares and sole dispositive power over all 31,312,064 shares.
- This filing is an amendment to a previous filing, with the event requiring this statement occurring on March 31, 2026.
- Dodge & Cox's clients, including investment companies and managed accounts, have the right to receive or direct dividends and sale proceeds from these securities.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive signal, as a major investment firm increasing or maintaining a significant stake suggests confidence in the company's future performance.
Positives
- Dodge & Cox, a significant investment manager, has taken a substantial stake in GE Healthcare Technologies Inc., signaling confidence in the company's prospects.
- The firm's clients benefit from the potential for dividends and proceeds from the sale of these shares.
Future Outlook
This filing does not contain specific forward-looking statements or guidance from GE Healthcare Technologies Inc. It solely reports on Dodge & Cox's ownership stake.
Industry Context
StockSavvy.ai notes that significant institutional ownership, as reported by Dodge & Cox, often indicates a level of confidence in a company's long-term strategy and financial stability within the healthcare technology sector.
Stakeholder Impact
- Shareholders: The increased or sustained institutional ownership may be viewed positively by other shareholders, potentially indicating stability and confidence in the company's management and strategy.
- Clients of Dodge & Cox: These clients benefit from the investment management services provided by Dodge & Cox, with their capital allocated to GE Healthcare Technologies Inc. based on the firm's investment strategy.
Next Steps
- Dodge & Cox will continue to hold and manage its stake in GE Healthcare Technologies Inc. on behalf of its clients.
- GE Healthcare Technologies Inc. will continue its operations and strategic initiatives as previously disclosed.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Date of event which requires filing of this statement (Amendment No. 2). |
| 05/14/2026 | Date of certification by Dodge & Cox's Chief Compliance Officer. |
Recommendation
holdThe filing indicates a significant institutional holding by Dodge & Cox, which suggests confidence. However, it is a disclosure of existing ownership and does not provide new operational or financial performance data for GE Healthcare Technologies Inc. itself. Therefore, a 'hold' recommendation is appropriate, pending further company-specific performance updates.
Keywords
GE Healthcare Technologies Inc., Dodge & Cox, Schedule 13G, Beneficial Ownership, Investment Management, Common Stock, SEC Filing, Shareholder
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.